Royalty Pharma EVP Christopher Hite disposes of 100,000 common shares worth $5,853,719.88

PUBT · 21h ago
Royalty Pharma EVP Christopher Hite disposes of 100,000 common shares worth $5,853,719.88
  • Royalty Pharma EVP and Chairman, Partnering Christopher Hite sold 100,000 Class A ordinary shares on Sep. 22.
  • Sales executed through SCH Investment Partners, reducing its stake to 270,401 shares; Hite still held 23,200 shares directly.
  • Disposals priced at USD 58.5148 and USD 58.9261 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001814238-26-000017), on September 24, 2026, and is solely responsible for the information contained therein.